ImmunityBio shares were up 14% to $3.52 after the company entered into a collaboration and supply agreement with BeiGene. The two companies will conduct a confirmatory randomized Phase 3 clinical ...

Session: Poster and Exhibition Hall Reception Poster Title:PALI-2108, a Colon-Specific PDE4B Inhibitor Prodrug is Activated in the Colon and Reduces Ulcerative Colitis Symptoms in an Acute Colitis DSS ...

ImmunityBio (IBRX) announced the European Medicines Agency has accepted for review and begun assessing the marketing authorization application ...

The global Veterinary Vaccines Market, valued at US$8.93 billion in 2023, is forecasted to grow at a robust CAGR of 6.1%, reaching ...

Investing.com -- ImmunityBio, an immunotherapy company, saw its shares surge by up to 20%, marking the most significant intraday rise since October 28. The spike in share price followed the company's ...

ST. LOUIS and GRIGGSVILLE, Ill., Jan. 16, 2025 /PRNewswire/ -- Pivot Bio, one of the world's leading innovative agtech companies, is proud to announce a retail distribution partnership with Logan ...

ImmunityBio shares rose after the company said it planned to submit multiple treatments for FDA commercial approval in 2025. Shares of the San Diego-based biotechnology company were recently up 16 ...

Shares of ImmunityBio (NASDAQ:IBRX) were up 15% in midday trading Thursday, the day after it issued updates on its regulatory submissions in the United States, European Union and United Kingdom ...

ImmunityBio achieved a 55% disease-free rate at 12 months for BCG-unresponsive NMIBC and plans an sBLA submission in 2025. NSCLC Phase 2b trial (N=86) showed a median overall survival of 14.1 ...

On Wednesday, ImmunityBio, Inc. (NASDAQ:IBRX) released progress in its ongoing FDA discussions regarding three areas of its clinical development pipeline in non-muscle invasive bladder cancer (NMIBC) ...

President Joe Biden calls for a constitutional amendment aimed at removing immunity for sitting presidents, advocating for greater accountability and transparency in the highest office.

Focusing on a child's immunity in their formative years is very important since it will benefit them throughout their lives. While prone to getting sick due to weaker immune systems, Children's ...